Cold Pain Therapy Market to reach US$ 4.9 Billion by 2027
The global Cold Pain Therapy market gathered revenue around USD 1.9 Billion in 2020 and market is set to grow USD 4.9 Billion by the end of 2027 and is estimated to expand at a modest CAGR of 5.2% during the prediction period 2021 to 2027. Factors such as increasing prevalence of arthritis and the rising number of sports injuries are the key factors boosting the demand for cold pain therapy products for the management of pain. Moreover, growing awareness about the availability of cost-effective cooling pain relief products and the ease of application of cold pain therapy products are anticipated to accelerate the adoption of these products in the coming years.
This research report purposes at stressing the most lucrative growth prospects. The aim of the research report is to provide an inclusive valuation of the Cold Pain Therapy market and it encompasses thoughtful visions, actualities, industry-validated market findings, historic data, and prognoses by means of appropriate set of assumptions and practice. Global Cold Pain Therapy market report aids in comprehending market structure and dynamics by recognizing and scrutinizing the market sectors and predicted the global market outlook.
COVID-19 Impact Assessment on Market Landscape
The report comprises the scrutiny of COVID-19 lock-down impact on the income of market leaders, disrupters and followers. Since lock down was instigated differently in diverse regions and nations, influence of same is also dissimilar across various industry verticals. The research report offers present short-term and long-term influence on the market to assist market participants across value chain makers to formulate the framework for short term and long-lasting tactics for recovery and by region.
Cold Pain Therapy market report empower readers with all-inclusive market intelligence and offers a granular outline of the market they are operational in. Further this research study delivers exceptional combination of tangible perceptions and qualitative scrutiny to aid companies accomplishes sustainable growth. This report employs industry-leading research practices and tools to assemble all-inclusive market studies, intermingled with pertinent data. Additionally, this report also emphases on the competitive examination of crucial players by analyzing their product portfolio, pricing, gross margins, financial position, growth approaches, and regional occurrence.
North America is the largest regional market for Cold pain therapy
North America (comprising the US and Canada) dominates cold pain therapy market. North America is a gaining traction with the increasing incidence and prevalence of orthopedic disoprders. Moreoer resence of major key platers in the region, facourable government scenarios, higher awarness of self tetsing and home care products and significant adoption of cold therapy products are likely to paly a major role in fueling the growth of the cold pain therapy market in the North America.
Competitive Rivalry
Foremost players in the market are attentive on adopting corporation strategies to enhance their market share. Some of the prominent tactics undertaken by leading market participants in order to sustain the fierce market completion include collaborations, acquisitions, substantial spending in R&D and the improvement of new-fangled products or reforms among others.
Significant Market Participants Operational in the Cold Pain Therapy Market are:
Sanofi (France), Pfizer (US), Hisamitsu Pharmaceutical (Japan), ROHTO Pharmaceutical (Japan), Beiersdorf (Germany), Johnson & Johnson (US), Medline Industries (US), Össur (Iceland), Performance Health (US), Breg (US), Romsons Group of Industries (India), Unexo Life Sciences (India), and Bird & Cronin (US).
Unravelling the Critical Segments
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:
By Product
By Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Cold Pain Therapy Market, By Product
7.1. Cold Pain Therapy Market, By Product, 2021-2027
7.1.1. OTC Products
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. Cold Packs
7.1.2.1. Market Revenue and Forecast (2016-2027)
7.1.3. Cooling Towels, Compresses, Wraps, and Pads
7.1.3.1. Market Revenue and Forecast (2016-2027)
7.1.4. Prescription Products
7.1.4.1. Market Revenue and Forecast (2016-2027)
Chapter 8. Global Cold Pain Therapy Market, Regional Estimates and Trend Forecast
8.1. North America
8.1.1. Market Revenue and Forecast, By Product (2016-2027)
8.1.2. U.S.
8.1.3. Rest of North America
8.1.3.1. Market Revenue and Forecast, By Product (2016-2027)
8.2. Europe
8.2.1. Market Revenue and Forecast, By Product (2016-2027)
8.2.2. UK
8.2.2.1. Market Revenue and Forecast, By Product (2016-2027)
8.2.3. France
8.2.3.1. Market Revenue and Forecast, By Product (2016-2027)
8.2.4. Rest of Europe
8.2.4.1. Market Revenue and Forecast, By Product (2016-2027)
8.3. APAC
8.3.1. Market Revenue and Forecast, By Product (2016-2027)
8.3.2. India
8.3.2.1. Market Revenue and Forecast, By Product (2016-2027)
8.3.3. China
8.3.3.1. Market Revenue and Forecast, By Product (2016-2027)
8.3.4. Japan
8.3.4.1. Market Revenue and Forecast, By Product (2016-2027)
8.3.5. Rest of APAC
8.3.5.1. Market Revenue and Forecast, By Product (2016-2027)
8.4. MEA
8.4.1. Market Revenue and Forecast, By Product (2016-2027)
8.4.2. GCC
8.4.2.1. Market Revenue and Forecast, By Product (2016-2027)
8.4.3. North Africa
8.4.3.1. Market Revenue and Forecast, By Product (2016-2027)
8.4.4. South Africa
8.4.4.1. Market Revenue and Forecast, By Product (2016-2027)
8.4.5. Rest of MEA
8.4.5.1. Market Revenue and Forecast, By Product (2016-2027)
8.5. Latin America
8.5.1. Market Revenue and Forecast, By Product (2016-2027)
8.5.2. Brazil
8.5.2.1. Market Revenue and Forecast, By Product (2016-2027)
8.5.3. Rest of LATAM
8.5.3.1. Market Revenue and Forecast, By Product (2016-2027)
Chapter 9. Company Profiles
9.1. Sanofi (France)
9.1.1. Company Overview
9.1.2. Product Offerings
9.1.3. Financial Performance
9.1.4. Recent Initiatives
9.2. Pfizer (US)
9.2.1. Company Overview
9.2.2. Product Offerings
9.2.3. Financial Performance
9.2.4. Recent Initiatives
9.3. Hisamitsu Pharmaceutical (Japan)
9.3.1. Company Overview
9.3.2. Product Offerings
9.3.3. Financial Performance
9.3.4. Recent Initiatives
9.4. ROHTO Pharmaceutical (Japan)
9.4.1. Company Overview
9.4.2. Product Offerings
9.4.3. Financial Performance
9.4.4. Recent Initiatives
9.5. Beiersdorf (Germany)
9.5.1. Company Overview
9.5.2. Product Offerings
9.5.3. Financial Performance
9.5.4. Recent Initiatives
9.6. Johnson & Johnson (US)
9.6.1. Company Overview
9.6.2. Product Offerings
9.6.3. Financial Performance
9.6.4. Recent Initiatives
9.7. Medline Industries (US)
9.7.1. Company Overview
9.7.2. Product Offerings
9.7.3. Financial Performance
9.7.4. Recent Initiatives
9.8. Össur (Iceland)
9.8.1. Company Overview
9.8.2. Product Offerings
9.8.3. Financial Performance
9.8.4. Recent Initiatives
9.9. Performance Health (US)
9.9.1. Company Overview
9.9.2. Product Offerings
9.9.3. Financial Performance
9.9.4. Recent Initiatives
9.10. Breg (US)
9.10.1. Company Overview
9.10.2. Product Offerings
9.10.3. Financial Performance
9.10.4. Recent Initiatives
9.11. Romsons Group of Industries (India)
9.11.1. Company Overview
9.11.2. Product Offerings
9.11.3. Financial Performance
9.11.4. Recent Initiatives
9.12. Unexo Life Sciences (India)
9.12.1. Company Overview
9.12.2. Product Offerings
9.12.3. Financial Performance
9.12.4. Recent Initiatives
9.13. Bird & Cronin (US)
9.13.1. Company Overview
9.13.2. Product Offerings
9.13.3. Financial Performance
9.13.4. Recent Initiatives
Chapter 10. Research Methodology
10.1. Primary Research
10.2. Secondary Research
10.3. Assumptions
Chapter 11. Appendix
11.1. About Us
11.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers